Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
European Journal of Pharmacology|May 10, 2024
Multi-omics study on the molecular mechanism of anlotinib in regulating tumor metabolismYu Lu, Xuedan Han, Hongwei Zhang, et al.Translational Oncology|December 31, 2024
PMAIP1-mediated glucose metabolism and its impact on the tumor microenvironment in breast cancer: Integration of multi-omics analysis and experimental validationYidong Zhang, Hang Xu, Xuedan Han, et al.Cancer Gene Therapy|August 16, 2025
Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human bladder cancerYu Lu, Fangdie Ye, Xuedan Han, et al.Journal of Pharmaceutical Analysis|September 11, 2024
Increasing the tumour targeting of antitumour drugs through anlotinib-mediated modulation of the extracellular matrix and the RhoA/ROCK signalling pathwayXuedan Han, Jialei Liu, Yidong Zhang, et al.Experimental and Therapeutic Medicine|May 2, 2022
FOXA1 transcription activates TFF1 to reduce 6-OHDA-induced dopaminergic neuron damageTingting Liang, Ping Zhao, Xiao Zhang, et al.Heliyon|August 2, 2024
Post-translational modifications: The potential ways for killing cancer stem cellsXuedan Han, Hai Qin, Yu Lu, et al.Proceedings of the National Academy of Sciences of the United States of America|April 8, 2026
Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancerFangdie Ye, Xuedan Han, Weijian Li, et al.Communications Biology|January 12, 2026
Fluvastatin suppresses breast cancer initiation and progression via targeting CYP4Z1Huilong Li, Ying Chen, Wanjin Shi, et al.Experimental & Molecular Medicine|July 2, 2026
ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progressionYin Yuan, Yu Lu, Xuedan Han, et al.Pageof 1